Replies to post #223023 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Edit: I get that the "worm-has-turned" on the chart.

I also get that LP stated nothing about further steps between getting (assumed) approval from four regulators and going to data lock -- although some here think they are going to conduct another data collection after getting the (assumed) approvals back.

I get that Dr. Fine, Dr. Stupp and Dr. Weller are three of only a handful of neurooncologists to diss DCVax-L.

I get that Dr. Bosch, Dr. Ashkan and Dr. Liau all believe DCVax-L seems to demonstrate efficacy, but it must be unblinded to confirm.

I get that the world of neuroncologists is waiting for this trial to release results.

I get all that. I also get that we need a sincere timeline expectation for topline. I also get that chart patterns are meant to be busted. Particularly in prerevenue companies.

I know there is great hope, I also know they need to simply give their best sincere estimate for topline timeline.

[Doc logic]

flipper44,

I think that Dr. Linda Liau and UCLA have a pretty good idea of when top line results will be released and if you can get her to comment you would probably have a reliable answer. NWBO seems to want as many ducks in a row as possible before they say anything. I think the journal snafu taught them what they are up against. They won't say anything until they have what they need in their hands. No more taking anyone's word for anything. Their experiences with Mr. Woodford, Ms Katherine Wolf, perhaps their former DMC chair, perhaps the former head of FDA, perhaps a strained relationship between the ex CEO of Cenkos and director Dr. Navid Malik and the journal issue I am sure have taught them some valuable lessons. Perhaps NWBO is about ready to teach some lessons of their own and they want the lesson plan very well organized and on their timeline instead of someone else's. Best wishes.